BSBrian M. Schmidt

Brian M. Schmidt

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Brian M. Schmidt has a total of 102 co-authors. Here are the top co-authors by number of shared publications:

  • Crystal M. Holmes

    Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, USA

    9 shared publications
  • James S. Wrobel

    Michigan Medicine, Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, Domino's Farms (Lobby C, Suite 1300) 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48106, United States of America

    4 shared publications
  • Rodica Pop-Busui

    Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Health, Ann Arbor, Michigan, USA

    4 shared publications
  • Christopher Girgis

    Michigan Medicine, Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, Domino's Farms (Lobby C, Suite 1300) 24 Frank Lloyd Wright Drive, Ann Arbor, Michigan 48106

    3 shared publications
  • Crystal M. Holmes

    University of Michigan Health, Department of Surgery, Vascular Surgery Section, Ann Arbor, MI, USA; University of Michigan Health, Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, Ann Arbor, MI, USA

    3 shared publications
  • Gary M. Rothenberg

    Division of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, MI, USA

    3 shared publications

Latest Publications

  • Improving the Severity Classification System of Diabetes-Related Foot Infections: Necrosis is a Better Predictor of Amputation Than Systemic Inflammatory Response

    by Justin J. Kim, Jennifer Fernandez, Ho D. Kim, Kelli J. McConnehey, Brian M. Schmidt

    Background. The International Working Group on the Diabetic Foot (IWGDF)/Infectious Disease Society of America (IDSA) classification system of diabetes-related foot infection (DFI) severity requires a severe infection to have the systemic inflammatory response syndrome (SIRS). Subsequent attempts to improve this classification system to include other clinically relevant characteristics (eg, necrosis and osteomyelitis) have not reliably predicted patient outcomes such as amputation. The purpose of this study was to propose an improved classification system based on clinically relevant predictors of amputation at our institution. Methods. This was a single-center, retrospective cohort study of 270 unique patients with 346 DFIs. We determined the association between clinical characteristics of each DFI (eg, cellulitis, abscess, necrosis, osteomyelitis, and SIRS) and amputation within 90 days of presentation. We derived a new severity classification system based on the presence of necrosis and compared the performance of this classification system to the IWGDF/IDSA classification system. Results. Our “necrosis classification system” predicted that mild, moderate, and severe DFI had a 20% (95% confidence interval [CI] 2%, 38%), 40% (95% CI [33%, 47%]), and 74% (95% CI [64%, 84%]) risk of amputation within 90 days of presentation, respectively, and discriminated between moderate and mild, and severe and moderate DFI. The IWGDF/IDSA classification system predicted that mild, moderate, and severe DFI had a 29% (95% CI [9%, 49%]), 43% (95% CI [36%, 50%]), and 54% (95% CI [44%, 63%]) risk of amputation within 90 days of presentation, respectively, and did not discriminate between moderate and mild, or severe and moderate DFI. Conclusion. This necrosis classification system discriminated the risk of amputation at 90 days better than the IWGDF/IDSA classification system. Our new classification system may have greater clinical relevance but needs to be validated to confirm its generalizability. Level of evidence: Level III: Retrospective comparative study

  • Do Immediate Perioperative Glucose Measurements Predict Outcomes in Non-Elective Pedal Amputation?

    by Christopher Girgis, Irina Gaynanova, Stephanie Behme, William H. Herman, Crystal Holmes, Brian M. Schmidt

    Background: Approximately 20% of diabetic foot ulcers progress to amputation. While elevated glucose levels are known to increase infection risk in elective surgeries, their role in outcomes following non-elective amputation remains unclear. Methods. We conducted a 2-year retrospective chart review of adult patients who underwent non-elective, diabetes-related lower-extremity amputations at a tertiary care health system. Of 185 charts reviewed, 108 patients with at least 6 months of follow-up were included. Preoperative and immediate postoperative glucose values were recorded. Primary and secondary outcomes included healing time, postoperative infection, emergency department visits, and hospital readmissions. Multivariable regression models were used to adjust for patient sex, amputation level, and relevant comorbidities. Results: The mean healing time was 13.8 weeks (SD 12.9). Elevated perioperative glucose (>180 mg/dL) was associated with a 42% increase in healing time (P = .037). Postoperative infections occurred in 14.8% of patients and were associated with an almost two-fold increase in healing time (P=.001), as well as increased rates of emergency department visits and readmissions. Peripheral arterial disease and end-stage renal disease were independently associated with delayed healing and higher readmission rates. Conclusion: Elevated perioperative glucose levels, postoperative infection, peripheral arterial disease, and end-stage renal disease are associated with prolonged wound healing and higher complication rates after non-elective lower-extremity amputations in patients with diabetes. These findings underscore the importance of perioperative glucose optimization, infection prevention, and comprehensive management of comorbidities to improve surgical outcomes in this high-risk population.

  • Biomarkers in Diabetic Foot

    by Hojin Lee, Alexandra Brown, Garneisha M. Torrence, Gary M. Rothenberg, Christopher Girgis, Noreen Anwar, Crystal M. Holmes, Brian M. Schmidt


  • Open Access

    Rethinking diabetic foot ulcer care: Integrating exercise and physical activity

    by Jane E. Nakamura, Angela J. Fong, Abbi D. Lane, Michael E. Munson, Brian M. Schmidt, Crystal M. Holmes, Jacob M. Haus


  • Microbial Dominance in Diabetic Foot Osteomyelitis Determined With Nanopore Sequencing Techniques Predicts Positive Response to Surgical Intervention

    by Brian M Schmidt, Piyush Ranjan, John Erb-Downward, Robert P Dickson

    Background: Tools to predict successful response to surgery for the treatment of diabetic foot osteomyelitis (OM) are currently lacking. Recent studies in nonbone infections have revealed that nanopore sequencing can provide real-time metagenomic identification of pathogens. In a cohort of patients with diabetic foot OM, we tested the feasibility of generating interpretable metagenomic data from surgically acquired osseous tissue, comparing bacterial community features (pathogen dominance) with clinical outcomes (resolution of infection). We hypothesized that nanopore-generated microbial data can be feasibly generated from surgically acquired bone, aligns with conventional culture results, and is predictive of clinical response. Methods: We performed a pilot feasibility study of 10 consecutive patients hospitalized with diabetic foot OM who underwent surgery for OM. We performed metagenomic sequencing of surgical bone samples using the MinION (Oxford Nanopore). Our primary metagenomic index was community dominance (relative abundance of most abundant species). Our primary clinical end point was the clinical response to surgery, adjudicated at 1 year. Results: We successfully generated interpretable metagenomic data from all 10 specimens, including 2 with negative culture growth. Among culture-positive specimens, the culture-identified pathogen was either the first or second most abundant organism in all cases. Patients with favorable clinical response exhibited greater pathogen dominance than those with unfavorable response (P = .002). Conclusions: In patients with surgically treated OM, nanopore sequencing can generate interpretable metagenomic data from bone specimens that are culture concordant and associated with clinical response. These findings support the feasibility and plausibility of using real-time metagenomic sequencing to improve the clinical management of OM.

  • High Transepidermal Water Loss at the Closed Wound Site Marks Compromised Functional Wound Closure and Associates with Wound Recurrence in Diabetic Foot Ulcers: A Prognostic Factor Study

    by Brian M. Schmidt, Cathie Spino, Charles Parks, Sashwati Roy, Gayle M. Gordillo, Crystal M. Holmes, Rodica Pop-Busui, Chandan K. Sen

    Objective: Wound closure is skin reepithelialization confirmed at two consecutive clinical visits 2 weeks apart. Our objective was to identify participant characteristics, including transepidermal water loss (TEWL), associated with complete wound closure of diabetic foot ulcers (DFUs) and reopening of a DFU within 2 weeks after initial closure in the National Institute of Diabetes and Digestive and Kidney Diseases-sponsored Diabetic Foot Consortium TEWL prospective observational cohort study of wound recurrence. At the site of wound closure, TEWL measures restoration of skin barrier function and functional wound closure. Approach: Four hundred and sixty-six eligible participants had physician-assessed wound closure at baseline. Of which, 418 (90%) had confirmed closure 2 weeks later and remained in the study, whereas 29 had their DFU reopen 2 weeks later and were not eligible for follow-up ( i.e., screen failures). We compared baseline characteristics of 418 enrolled and 29 screen fail individuals using Wilcoxon rank sum and Fisher’s exact tests p value for continuous and categorical outcomes, respectively. Results: There were no statistically significant differences in demographics, including age, sex, race, education, employment status, social support, or dressing change requirements between groups. The failure to maintain closure group had longer median duration of index DFU before initial closure (25.8 vs. 14 weeks, p = 0.003), higher frequency of prior total contact casting use (37% vs. 14%, p = 0.003), and a higher median initial TEWL measurement at the healed ulcer midpoint (27.1 vs. 21.0 g/m 2/h , p = 0.006). Innovation: TEWL measurement at the site of wound closure can assess functional capacity of the skin in conjunction with current standards of wound closure end point in DFU and has significant potential to add quantitative measurement to assist in clinical assessment of healing wounds. Conclusion: Individuals with DFU who did not maintain wound closure had higher TEWL values at baseline, longer DFU wound duration, and more prior off-loading use. These findings are clinically relevant as a higher TEWL measurement demonstrates incomplete functional wound closure, supporting the use of TEWL to identify a healed DFU.


  • Post-operative instructions are essential to preventing recurrent infection after amputation

    by Stephanie Behme, Christopher Girgis, Garneisha M. Torrence, Elizabeth Tronstein, Brian M. Schmidt, Crystal M. Holmes

  • Understanding Patient Preferences Regarding Limb Salvage for Diabetic Foot Ulcers: A Discrete Choice Experiment

    by Lyndsay M. O’HAra, Alison D. Lydecker, Gwen L. Robinson, Nathan N. O’HAra, Justin J. Kim, Alyson J. Littman, Brian M. Schmidt, Odessa Addison, David J. Margolis, Mary-Claire Roghmann

    OBJECTIVE: Diabetic foot ulcers (DFUs) often lead to amputations. Limb salvage aims to preserve the lower extremity, but the complexity of care and uncertainty of healing can delay patients’ return to normal activities. This study aimed to understand military veterans’ preferences regarding limb salvage for DFUs, using a discrete choice experiment (DCE). RESEARCH DESIGN AND METHODS: A DCE was conducted with 98 veterans with diabetes at the Baltimore Veterans Affairs Medical Center. Participants were presented with 10 choice sets involving different levels of postrecovery mobility, amputation levels, and future surgery risks. These attributes were developed through literature review and interviews. Data were analyzed using a multinomial logit model to estimate the utility of each attribute level and assess preference heterogeneity. RESULTS: The study population was older (mean age 69 years), Black (61%), and male (94%). Half (53%) had a prior foot complication. Postrecovery mobility was the most important attribute (relative importance 53%), followed by amputation level (30%) and future surgery risk (18%). Veterans valued mobility highly, with significant utility differences between walking unaided and needing a wheelchair or scooter. They were willing to accept higher amputation levels to improve mobility. CONCLUSIONS: Postrecovery mobility is a critical factor for veterans with DFUs, outweighing concerns about amputation level and future surgical risks. It should be a focus of shared decision-making. The study is limited by its single-site setting and study population. Broader research is needed. Understanding patient preferences through DCE can inform more patient-centered approaches to DFU management, potentially improving outcomes and satisfaction.


  • Impact of Podiatric Surveillance on Amputation Rates in Patients with Diabetes and Chronic Kidney Disease

    by Stephanie Behme, Christopher Girgis, Brian M. Schmidt

    Development of the triad of peripheral arterial disease, peripheral neuropathy, and end stage renal disease puts people with diabetes at an increased risk of diabetic foot ulcerations and subsequent infections that often precede lower extremity amputations. In patients on hemodialysis, there is a ten-fold increased risk of amputation and an estimated 40%-82% one-year mortality rate if the amputation is a major amputation. This study aimed to examine if patients presenting to a podiatric clinic with stage 3a or 3b chronic kidney disease and a diabetic foot ulcer had decreased rates of amputations as compared to patients who presented after initiating dialysis. Our results demonstrated all major amputations occurred in patients who did not establish with podiatry prior to initiating HD. Additionally, our study revealed a potential access to care disparity for African American patients with chronic kidney disease, as African American patients were established with podiatry prior to initiating dialysis less often in comparison to Caucasian individuals. Our study lays the groundwork for future work investigating the impact of podiatric surveillance on patients with diabetes and end stage renal disease.